Google News

Move Aside Retatrutide, Eli Lilly Just Beat Its Next-Gen Obesity Drug - Investor's Business Daily

Sep 30, 2026, 8:09 PM

Translate article text

Choose a language and wait for the translated text.

Move Aside Retatrutide, Eli Lilly Just Beat Its Next-Gen Obesity Drug  Investor's Business Daily